333 related articles for article (PubMed ID: 15679176)
1. Drug delivery and in vitro models of the blood-brain barrier.
Cucullo L; Aumayr B; Rapp E; Janigro D
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):89-99. PubMed ID: 15679176
[TBL] [Abstract][Full Text] [Related]
2. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
[TBL] [Abstract][Full Text] [Related]
3. Current in vitro and in silico models of blood-brain barrier penetration: a practical view.
Vastag M; Keseru GM
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):115-24. PubMed ID: 19152220
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of the blood-brain barrier: animal models and methods.
Hawkins BT; Egleton RD
Curr Top Dev Biol; 2008; 80():277-309. PubMed ID: 17950377
[TBL] [Abstract][Full Text] [Related]
5. Applications of a blood-brain barrier technology platform to predict CNS penetration of various chemotherapeutic agents. 1. Anti-infective drugs.
Adenot M; Perriere N; Scherrmann JM; Lahana R
Chemotherapy; 2007; 53(1):70-2. PubMed ID: 17202814
[TBL] [Abstract][Full Text] [Related]
6. Nanobiotechnology-based drug delivery to the central nervous system.
Jain KK
Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
[TBL] [Abstract][Full Text] [Related]
7. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies.
Cucullo L; Couraud PO; Weksler B; Romero IA; Hossain M; Rapp E; Janigro D
J Cereb Blood Flow Metab; 2008 Feb; 28(2):312-28. PubMed ID: 17609686
[TBL] [Abstract][Full Text] [Related]
8. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
Correale J; Villa A
Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
Allen DD; Geldenhuys WJ
Life Sci; 2006 Feb; 78(10):1029-33. PubMed ID: 16126231
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
Garcia-Garcia E; Andrieux K; Gil S; Couvreur P
Int J Pharm; 2005 Jul; 298(2):274-92. PubMed ID: 15896933
[TBL] [Abstract][Full Text] [Related]
12. Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study.
Santaguida S; Janigro D; Hossain M; Oby E; Rapp E; Cucullo L
Brain Res; 2006 Sep; 1109(1):1-13. PubMed ID: 16857178
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier imaging and therapeutic potentials.
Rebeles F; Fink J; Anzai Y; Maravilla KR
Top Magn Reson Imaging; 2006 Apr; 17(2):107-16. PubMed ID: 17198226
[TBL] [Abstract][Full Text] [Related]
14. Progress in brain penetration evaluation in drug discovery and development.
Liu X; Chen C; Smith BJ
J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
[TBL] [Abstract][Full Text] [Related]
15. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
16. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
17. Potential of biopartitioning micellar chromatography as an in vitro technique for predicting drug penetration across the blood-brain barrier.
Escuder-Gilabert L; Molero-Monfort M; Villanueva-Camañas RM; Sagrado S; Medina-Hernández MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):193-201. PubMed ID: 15203029
[TBL] [Abstract][Full Text] [Related]
18. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier permeation models: discriminating between potential CNS and non-CNS drugs including P-glycoprotein substrates.
Adenot M; Lahana R
J Chem Inf Comput Sci; 2004; 44(1):239-48. PubMed ID: 14741033
[TBL] [Abstract][Full Text] [Related]
20. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept.
Reichel A
Chem Biodivers; 2009 Nov; 6(11):2030-49. PubMed ID: 19937839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
